HEALTHTREE

Sign In / Join

Menu

close

pinned-large-article

Richard Abraham's Myeloma Journey With the Elephant on His Back

Life with Myeloma — May 23, 2022

Richard Abraham's shares his myeloma journey from diagnosis to today's treatments

Real-World Data on CAR T-Cell Therapy in Multiple Myeloma

Elotuzomab Triplet Disappoints For Newly Diagnosed, Transplant Ineligible Myeloma Patients

The Mental Battle of Myeloma

Upcoming Events

May 26, 2022 / 02:00PM - 03:00PM EDT

Changing Your Diet while Keeping Your Culture

African American Myeloma Chapter

View details chevron_right

May 26, 2022 / 07:00PM - 08:00PM EDT

Clinical Trials for Newly Diagnosed Myeloma Patients with John Rosengard

Newly Diagnosed Myeloma Patients Chapter

View details chevron_right

Jun 02, 2022 / 07:00PM - 08:00PM EDT

Water Aerobics: The Benefits for Myeloma Patients

HealthTree Moves for Myeloma Chapter

View details chevron_right

Jun 07, 2022 / 01:00PM - 02:00PM EDT

Medical Appeals Insurance Workshop for Myeloma Patients/Caregivers

Myeloma Financial Chapter

View details chevron_right

Jun 08, 2022 / 01:00PM - 02:00PM EDT

Tracking Your Myeloma Labs in HealthTree Cure Hub (with the Patient Experience Team)

Connect with the Myeloma Crowd Chapter

View details chevron_right

View all events

list-recent-article

Higher Rates of Melanoma in Patients with Multiple Myeloma

Life with Myeloma—May 16, 2022

Patients with Multiple Myeloma have Higher Rates of Getting the Skin Cancer, Melanoma

list-recent-article

First Trispecific Antibody in Multiple Myeloma Enters Development Track

Myeloma News—May 16, 2022

The first trispecific antibody for multiple myeloma has entered the development cycle

list-recent-article

Negative PET Scans after Initial Myeloma Treatment Shows Advantages for Outcomes

Myeloma News—May 13, 2022

Negative PET Scans Following Initial Myeloma Therapy Shows Better Survival and Longer Remissions

list-recent-article

Links Between Psoriasis and Multiple Myeloma

HealthTree Research—May 13, 2022

HealthTree Cure Hub Explored the Links Between Psoriasis and Multiple Myeloma

list-recent-article

Why Multiple Myeloma Returns After Immunomodulator Therapy

Myeloma News—May 12, 2022

Why Multiple Myeloma Returns After Immunomodulator Therapy (lenalidomide and pomalidomide)

Myeloma News

category-article

Elotuzomab Triplet Disappoints For Newly Diagnosed, Transplant Ineligible Myeloma Patients First Trispecific Antibody in Multiple Myeloma Enters Development Track Negative PET Scans after Initial Myeloma Treatment Shows Advantages for Outcomes

Life with Myeloma

category-article

Richard Abraham's Myeloma Journey With the Elephant on His Back Higher Rates of Melanoma in Patients with Multiple Myeloma Myeloma Patient Stories: The Bus Station

MC Radio

category-article

Full Show: Looking Forward into 2022 in Multiple Myeloma With Robert Orlowski, MD, PHD, MD Anderson Cancer Center Full Show: Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic Full Show: Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD

MC Events

category-article

The Relationship Between Inflammation and Myeloma How To Live with Myeloma Without Defining Yourself By It How to Determine Whether or Not a Stem Cell Transplant is Successful with Dr. Guido Tricot

Myeloma Clinical Trials

category-article

Clinical Trial: Can Yoga Help Alleviate Peripheral Neuropathy After Chemo? Clinical Trial: A New Myeloma Therapy Tasquinimod Targeting MDSCs Debunking Clinical Trial Myths with Dr. Craig Cole

Myeloma 101

category-article

Velcade and Green Tea: A Myeloma No-No Multiple Myeloma and the 4;14 Translocation What to Ask Your Doctor at Your First Multiple Myeloma Appointment

Upcoming MC Round Tables

category-article

Myeloma Crowd Round Table in Berlin, Germany on June 4

Myeloma Coach

category-article

The Mental Battle of Myeloma Understanding the Nuances of Medicare Can Save you Money and Heartache Self Education: The Basis of Better Health Outcomes Physically, Mentally and Financially

HealthTree University

category-article

How Can I Improve My Immune System With Multiple Myeloma? What are Bispecific Antibodies and How are They Used in Treating Multiple Myeloma? What are Antibodies and How are They Used in Multiple Myeloma?

Thanks to our HealthTree Community for Myeloma Sponsors:

Abbvie

Bristol Myers Squibb

Janssen Oncology

GSK

Follow Us

instagram

youtube

Copyright © 2021 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811